Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Bevacizumab
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 400 mg/16 mL
- Dosage form
- Solution for infusion
- Pack
- 1's
- Registration no.
- 120493
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Cizumab EU 400 mg/16 mL solution for infusion
Cizumab EU 400 mg/16 mL solution for infusion contains Bevacizumab 400 mg/16 mL. It is registered with DRAP by The Searle Company Limited (registration no. 120493). Its official price is PKR 102,238.25 for a pack of 1's. This price has applied since 23 July 2026. Cizumab EU is also available as 100 mg/4 mL (25 mg/mL) concentrate for infusion. 4 other brands of Bevacizumab 400 mg/16 mL (solution for infusion) are registered in Pakistan. Compare all brands and prices →
Other strengths of Cizumab EU
All 4 other brands of Bevacizumab 400 mg/16 mL infusion in Pakistan
These 4 brands are alternatives (substitutes) to Cizumab EU: each contains Bevacizumab 400 mg/16 mL infusion. Ask your doctor or pharmacist before you switch brands.
Sorted by price per unit, lowest first. The lowest is BAZUMAB (Hilton Pharma (Pvt) Limited) at PKR 91,712 per unit; the highest is Avastin at PKR 236,487. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| BAZUMAB | Hilton Pharma (Pvt) Limited | 16mlx1's | PKR 91,711.79 | PKR 91,712 / unit |
| STIVANT | CCL Pharmaceuticals (Pvt.) Limited | 1's | PKR 102,238.25 | PKR 102,238 / unit |
| Cizumab | The Searle Company Limited | 1's | PKR 132,267.99 | PKR 132,268 / unit |
| Avastin | Roche Pakistan Ltd | 1's | PKR 236,486.52 | PKR 236,487 / unit |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Cizumab EU, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- The Searle Company Limited, Karachi
- DRAP registration
- 120493
- Phone
- +92 21 37170200-201
- info@searlecompany.com
- Website
- https://searlecompany.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 102,238.25, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Cizumab EU 400 mg/16 mL, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/cizumab-eu-400-mg-16-ml-120493-1s-the-searle-company-limited/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 102,238.25 | 2026-07-23 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 120493Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.